Literature DB >> 9217975

The neuropathology of CAG repeat diseases: review and update of genetic and molecular features.

Y Robitaille1, I Lopes-Cendes, M Becher, G Rouleau, A W Clark.   

Abstract

Classification of inherited neurodegenerative diseases is increasingly based on their genetic features, which supplement, clarify, and sometimes replace the older clinical and pathologic schemata. This change has been particularly rapid and impressive for the CAG repeat disorders. In Huntington's disease, X-linked spinobulbar muscular atrophy, dentatorubropallidoluysian atrophy, and a series of autosomal dominant cerebellar atrophies, genetic advances have resolved many nosologic issues, and opened new avenues for exploration of pathogenesis. In this review, we summarize classic and current concepts in neuropathology of these CAG repeat diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9217975     DOI: 10.1111/j.1750-3639.1997.tb00893.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  24 in total

1.  The cerebellar component of Friedreich's ataxia.

Authors:  Arnulf H Koeppen; Ashley N Davis; Jennifer A Morral
Journal:  Acta Neuropathol       Date:  2011-06-03       Impact factor: 17.088

2.  Role of glutamine deamidation in neurodegenerative diseases associated with triplet repeat expansions: a hypothesis.

Authors:  Qurratulain Hasan; Ravindra Varma Alluri; Pragna Rao; Yog Raj Ahuja
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Authors:  P C Wong; H Cai; D R Borchelt; D L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

4.  Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration.

Authors:  Y Hellenbroich; K Gierga; E Reusche; E Schwinger; T Deller; R A I de Vos; C Zühlke; U Rüb
Journal:  J Neural Transm (Vienna)       Date:  2005-12-19       Impact factor: 3.575

Review 5.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

6.  Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

Authors:  B O Evert; I R Vogt; C Kindermann; L Ozimek; R A de Vos; E R Brunt; I Schmitt; T Klockgether; U Wüllner
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

7.  Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

Authors:  Kai-Hsiang Chen; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  BMJ Case Rep       Date:  2012-03-20

8.  Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Jeffrey H Kordower; Pedro Gonzalez-Alegre; Beverly L Davidson
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

Review 9.  Mahogunin Ring Finger-1 (MGRN1), a Multifaceted Ubiquitin Ligase: Recent Unraveling of Neurobiological Mechanisms.

Authors:  Arun Upadhyay; Ayeman Amanullah; Deepak Chhangani; Ribhav Mishra; Amit Prasad; Amit Mishra
Journal:  Mol Neurobiol       Date:  2015-08-09       Impact factor: 5.590

10.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Authors:  Nigel J Cairns; Manuela Neumann; Eileen H Bigio; Ida E Holm; Dirk Troost; Kimmo J Hatanpaa; Chan Foong; Charles L White; Julie A Schneider; Hans A Kretzschmar; Deborah Carter; Lisa Taylor-Reinwald; Katherine Paulsmeyer; Jeffrey Strider; Michael Gitcho; Alison M Goate; John C Morris; Manjari Mishra; Linda K Kwong; Anna Stieber; Yan Xu; Mark S Forman; John Q Trojanowski; Virginia M-Y Lee; Ian R A Mackenzie
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.